Skip to main content
. 2015 May 1;29(5):279–287. doi: 10.1089/apc.2014.0346

Table 2.

HIV Care Engagement, Antiretroviral Therapy, Substance Use, and Depression Among CAPP Participants Who Completed Baseline Surveys

  All participants (N=247) N (%) Surveillance-identified (N=188) N (%) Referred (N=59) No.
Ever linked to HIV carea
 Yes 228 (92) 175 (93) 53 (90)
 No 11 (4) 5 (3) 6 (10)
 Missing 8 (3) 8 (4) 0 (0)
Has a medical providera
 Yes 187 (77) 150 (81) 37 (63)
 No 57 (23) 35 (22) 22 (37)
Has a case managera
 Yes 132 (54) 101 (55) 31 (53)
 No 99 (40) 73 (26) 26 (44)
 Unsure 16 (6) 14 (8) 2 (3)
Ever on ART
 Yes 181 (73) 141 (75) 40 (68)
 No 60 (24) 42 (22) 18 (31)
 Unsure/refused to answer 6 (2) 5 (3) 1 (2)
  Discontinued ART (N=181)
   Yes 138 (76) 106 (75) 32 (80)
   No 39 (22) 32 (23) 7 (18)
   Unsure/refused to answer 4 (2) 2 (1) 1 (3)
Current ART prescriptiona
 Yes 109 (44) 92 (49) 17 (29)
 No 134 (54) 92 (49) 42 (71)
 Unsure/refused to answer 4 (2) 4 (3) 0 (0)
Current health insurancea
 Yes 159 (64) 131 (70) 28 (47)
 No 77 (31) 49 (26) 28 (47)
 Unsure/refused to answer 11 (5) 8 (4) 3 (5)
Depression screen
 Positive 171 (69) 127 (68) 44 (75)
 Negative 72 (29) 59 (31) 13 (22)
 Refused 4 (2) 2 (1) 2 (3)
Current substance usea,b
 Heroin 16 (6) 12 (6) 4 (7)
 Methamphetamine 64 (26) 35 (19) 29 (49)
 Cocaine or crack-cocaine 16 (6) 13 (7) 3 (5)
 Hazardous alcohol 37 (15) 31 (16) 6 (10)
 None of the above 114 (46) 97 (52) 17 (29)

CAPP, The Care and Antiretroviral Promotion Program; ART, antiretroviral therapy.

a

p<0.05 for chi-square test comparing surveillance identified to referred CAPP participants. bCategories are mutually exclusive and hierarchical in the order listed.